Simulations Plus/SLP

$41.83

0.77%
-
1D1W1MYTD1YMAX

About Simulations Plus

Simulations Plus, Inc. is a provider of modeling and simulation software and services for pharmaceutical drug discovery and development, including the prediction of properties of molecules utilizing both artificial intelligence and machine-based technology. The Company's segments include software and services. It offers 12 software products for pharmaceutical research and development: GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, MonolixSuite, ADMET Predictor and MedChem Designer. Its services include population pharmacokinetic and pharmacodynamic, quantitative systems pharmacology/quantitative systems toxicology, and physiologically based pharmacokinetic. The Company provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions supporting product approval. Its software and consulting services are provided to various industries, including biotechnology and cosmetics.

Ticker

SLP

Sector

Healthcare

Trading on

NASDAQ

Industry

Software & Programming

CEO

Shawn O'Connor

Employees

192

Headquarters

Lancaster, United States

Simulations Plus Metrics

BasicAdvanced
$828.83M
Market cap
79.46
P/E ratio
$0.52
EPS
0.72
Beta
$0.24
Dividend rate
0.58%
Dividend yield

What the Analysts think about Simulations Plus

Analyst Ratings

Majority rating from 3 analysts.
Buy

Price Targets

Average projection from 3 analysts.
28.31% upside
High $55.00
Low $51.00
$41.83
Current price
$53.67
Average price target

Simulations Plus Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
13.1% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$14.5M
-7.05%
Net income
$1.9M
280%
Profit margin
13.1%
309.38%

Simulations Plus Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 0%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.20
$0.20
$0.02
$0.10
-
Expected
$0.18
$0.20
$0.18
$0.10
$0.19
Surprise
11.11%
-1.64%
-89.09%
0%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Simulations Plus stock

Buy or sell Simulations Plus stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing